Audio Overview Dr
With newer molecules targeting multiple pathways (GLP-1, GIP, glucagon, amylin, insulin), the scope is expanding well beyond diabetes and weight management, towards cardiometabolic health, neurodegenerative disorders, and even oncology
This represents a big step forward, as drug manufacturers have shied away from investing in research for adjunctive therapies in the past
Type 2 diabetes mellitus (T2DM) is a complex and progressive disease associated with significant morbidity and mortality
Wegovy is now available in both pill and injectable forms, offering more flexibility for weight-loss treatment
If you want rapid, drug-level results, you may feel disappointed and assume it is a scam when, in fact, the issue is unrealistic expectations